Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26.8M
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
1.5M
-
Shares change
-
+349K
-
Total reported value, excl. options
-
$12M
-
Value change
-
+$2.82M
-
Number of buys
-
8
-
Number of sells
-
-4
-
Price
-
$8.00
Significant Holders of Eton Pharmaceuticals, Inc. - Common Stock (ETON) as of Q1 2019
15 filings reported holding ETON - Eton Pharmaceuticals, Inc. - Common Stock as of Q1 2019.
Eton Pharmaceuticals, Inc. - Common Stock (ETON) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.5M shares
of 26.8M outstanding shares and own 5.59% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (765K shares), AWM Investment Company, Inc. (425K shares), Diametric Capital, LP (122K shares), Apollo Management Holdings, L.P. (90K shares), PRELUDE CAPITAL MANAGEMENT, LLC (36.8K shares), VANGUARD GROUP INC (27K shares), BlackRock Inc. (9.28K shares), BARCLAYS PLC (8.8K shares), UBS Group AG (8.54K shares), and WELLS FARGO & COMPANY/MN (6K shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.